2/16/2014. Low Dose Ketamine...Everything? How do you use ketamine in your practice of emergency medicine?

Similar documents
Pain Management in the Critically ill Patient

9/16/2010. Contact Information. Objectives. Analgesic Ketamine (Ketalar )

POST-TEST Pain Resource Professional Training Program University of Wisconsin Hospital & Clinics

Alison White Devang Rai Richard Chye

Treatment of Opioid Dependence with Buprenorphine/Naloxone (Suboxone )

Evaluation of a Morphine Weaning Protocol in Pediatric Intensive Care Patients

DEMENTIA EDUCATION & TRAINING PROGRAM

Acute Pain Management in the Opioid Dependent Patient. Maripat Welz-Bosna MSN, CRNP-BC

Naloxone treatment of opioid overdose

Phenobarbital in Severe Alcohol Withdrawal Syndrome. Jordan Rowe Pharm.D. Candidate UAMS College of Pharmacy

Update on Buprenorphine: Induction and Ongoing Care

New York State Office of Alcoholism & Substance Abuse Services Addiction Services for Prevention, Treatment, Recovery

Objectives. Important Principles

Acute pain management for opioid tolerant patients CLASSIFICATION OF OPIOID TOLERANT PATIENTS

October We hope that our tool will be a useful aid in your efforts to improve pain management in your setting. Sincerely,

Lidocaine Infusion for Perioperative Pain Management. Marley Linder, PharmD Matt McEvoy, MD

VA SAN DIEGO HEALTHCARE SYSTEM MEMORANDUM SAN DIEGO, CA

Passionate concerns about welfare and ethics have created an environment where discussions about

DEVELOPING MANUFACTURING SUPPLYING. Naltrexone Implants. Manufactured by NalPharm Ltd

Alcohol Withdrawal Syndromes

1. According to recent US national estimates, which of the following substances is associated

PROTOCOL SYNOPSIS Evaluation of long-term opioid efficacy for chronic pain

Ketamine in Tactical Combat Casualty Care. DHB Decision Briefing. John Gandy, MD Trauma and Injury Subcommittee

PHSW Procedural Sedation Post-Test Answer Key. For the following questions, circle the letter of the correct answer(s) or the word true or false.

Clinical Algorithm & Preferred Medications to Treat Pain in Dialysis Patients

Review of Pharmacological Pain Management

PROCEDURAL SEDATION/ANALGESIA NCBON Position Statement for RN Practice

Acute & Chronic Pain Management (requiring opioid analgesics) in Patients Receiving Pharmacotherapy for Opioid Addiction

The patient s response to therapy within the first hour in the Emergency Room is one of the most reliable ways to predict need for hospitalization.

Glasgow Assessment and Management of Alcohol

Case Studies: Acute pain management in patients with opioid addiction. Shannon Levesque, PharmD Clinical Pharmacist

Nurses Self Paced Learning Module on Pain Management

4/13/15. Case 1. COWS = Clinical Opioid Withdrawal Scale. Special Populations

WITHDRAWAL OF ANALGESIA AND SEDATION

Implementing Prescribing Guidelines in the Emergency Department. April 16, 2013

OPIOID CONVERSIONS. 2. Add a rescue doses (IR) of same opioid if possible should be~10 20% of total daily opioid dose

Abstral Prescriber and Pharmacist Guide

Arkansas Emergency Department Opioid Prescribing Guidelines

OVERVIEW OF MEDICATION ASSISTED TREATMENT

DRAFT 7/17/07. Procedural Sedation and Rapid Sequence Intubation (RSI) Consensus Statement

Buprenorphine/Naloxone Maintenance Treatment for Opioid Dependence

Philip Moore DO, Toxicology Fellow, PinnacleHealth Toxicology Center Joanne Konick-McMahan RN MSRN, Staff RN, PinnacleHealth

Transitioning Chronic Pain Patients Out of the Hospital. Rosemary Quirk, MD, DTMH ACP, November 7, 2014

2.0 Synopsis. Vicodin CR (ABT-712) M Clinical Study Report R&D/07/095. (For National Authority Use Only) to Part of Dossier: Volume:

Alcohol Withdrawal. Introduction. Blood Alcohol Concentration. DSM-IV Criteria/Alcohol Abuse. Pharmacologic Effects of Alcohol

Summary of State Emergency Medical Control Committee (SEMCC) Approved Protocol Revisions September 1, 2015 NALOXONE

Nurse Practitioner Emergency Services CLINICAL PRACTICE GUIDELINE

HOWS AND WHYS OF CRI ANALGESIA IN SMALL ANIMALS Luisito S. Pablo, DVM, MS, Diplomate ACVA University of Florida, Gainesville, Florida

Feline Anesthesia Richard M. Bednarski, DVM, MSc The Ohio State University College of Veterinary Medicine Current Issues in Feline Anesthesia

GUIDELINE FOR ADMINISTRATION OF FENTANYL FOR PAIN RELIEF IN LABOUR

Clinical Research Pediatric Pulmonary Division

MEDICATION ABUSE IN OLDER ADULTS

Lumbar Fusion. Reference Guide for PACU CLINICAL PATHWAY. All patient variances to the pathway are to be circled and addressed in the progress notes.

GUIDELINES ON THE MANAGEMENT OF PAIN DUE TO CANCER IN ADULTS

Diabetes Expert Witness on: Diabetic Hypoglycemia in Nursing Homes

Prior Authorization Guideline

The Pharmacological Management of Cancer Pain in Adults. Clinical Audit Tool

One example: Chapman and Huygens, 1988, British Journal of Addiction

Naloxone Hydrochloride Injection PRODUCT INFORMATION

Test Content Outline Effective Date: June 9, Pain Management Nursing Board Certification Examination

4/18/14. Background. Evaluation of a Morphine Weaning Protocol in Pediatric Intensive Care Patients. Background. Signs and Symptoms of Withdrawal

Use of Vivitrol for Alcohol and Opioid Addiction

MODERATE SEDATION RECORD (formerly termed Conscious Sedation)

Palliative Medicine, Pain Management, and Hospice. Devon Neale, MD Assistant Professor Dept of Internal Medicine UNM School of Medicine

NALTREXONE INDUCED DETOXIFICATION FROM OPIOIDS A METHOD OF ANTAGONIST INITIATED TREATMENT

New Jersey EMS Response to an Opiate Overdose Naloxone (Narcan ) Program **Updated March 26, 2015**

Neurobiology and Treatment of Opioid Dependence. Nebraska MAT Training September 29, 2011

Objectives COPD. Chronic Obstructive Pulmonary Disease (COPD) 4/19/2011

UNIT VIII NARCOTIC ANALGESIA

A HISTORICAL PERSPECTIVE ON HUMAN ABUSE LIABILITY STUDIES. Donald R Jasinski, MD

Naltrexone for Opioid & Alcohol Use Disorders

Downers/Depressants (pages 40-50)

Treatment of Opioid Dependence: A Randomized Controlled Trial. Karen L. Sees, DO, Kevin L. Delucchi, PhD, Carmen Masson, PhD, Amy

DOCUMENTATION TEMPLATES. All patient care reports should include the following information in the narrative:

Assessment and Management of Opioid, Benzodiazepine, and Sedative-Hypnotic Withdrawal

Pain Control Aims. General principles of pain control. Basic pharmacokinetics. Case history demo. Opioids renal failure John Welsh 8/4/2010

American Dental Association Providers Clinical Support System on Opioid Therapies Webinar

Medical marijuana for pain and anxiety: A primer for methadone physicians. Meldon Kahan MD CPSO Methadone Prescribers Conference November 6, 2015

Treatment of opioid use disorders

Information for Pharmacists

MOH CLINICAL PRACTICE GUIDELINES 2/2008 Prescribing of Benzodiazepines

Head Injury. Dr Sally McCarthy Medical Director ECI

CH CONSCIOUS SEDATION

PRACTICE Guidelines are systematically developed recommendations

26. ACUTE PAIN MANAGEMENT IN THE FIELD

Pain, Addiction & Methadone

Procedure -8. Intraosseous Infusion Adult and Pediatric EZIO. Page 1 of 7 APPROVED:

7. We often use Marcaine in tonsillectomies for longer acting analgesia. What is the dose? What are the particular side effects?

Questions and answers on breast cancer Guideline 10: The management of persistent pain after breast cancer treatment

Care Management Council submission date: August Contact Information

MEDICATION ASSISTED TREATMENT FOR OPIOID ADDICTION

South Denver Prehospital Services 2014

PARTNERSHIP HEALTHPLAN RECOMMENDATIONS For Safe Use of Opioid Medications

Opioid Analgesics. Week 19

Proposal for deletion Codeine phosphate tablets for pain in children

Alcohol Overuse and Abuse

Asthma. Micah Long, MD

Opioid Addiction & Methadone Maintenance Treatment. What is Methadone? What is an Opioid?

Guidelines for the Use of Naloxone in Palliative Care in Adult Patients

Naltrexone Pellet Treatment for Opiate, Heroin, and Alcohol Addiction. Frequently Asked Questions

Transcription:

How do you use ketamine in your practice of emergency medicine? Low Dose Ketamine...Everything? Craig Smollin MD Associate Medical Director, California Poison Control Center, SF Division Assistant Professor of Emergency Medicine, UCSF Procedural sedation in children? Adults? Induction agent for RSI? Treatment of pain Control of the agitated patient Is there more than anecdotal evidence to the use of low dose ketamine? Objectives History and pharmacology of ketamine Anesthetic vs. sub-anesthetic doses of ketamine Clinical scenarios and evidence taken from Saturday Morning Breakfast http://www.smbc-comics.com 1

The history of ketamine starts with PCP The history of ketamine starts with PCP 1958: Phencyclidine (PCP) introduced into clinical anesthesia Anesthetic effects attributed to NMDA receptor antagonism Hallucinations, confusion, and delirium led to its discontinued use in humans PCP Phencyclidine Ketamine Ketamine History 1962: Ketamine synthesized by Stevens 1965: Ketamine trials in humans. Most promising of 200 different PCP derivatives 1970: Ketamine released for clinical use in U.S. Ketamine 2

Mechanism of action NMDA Receptors Complex pharmacology Non-competative NMDA receptor antagonist Neurotransmitter glutamate Glutamate released with noxious peripheral stimuli Activation of NMDA receptors associated: Hyperalgesia Neuropathic pain Reduced opioid sensitivity. Dissociative Dosing What is low-dose Ketamine? Route Dose Onset Time to peak effect Duration of action Intravenous 1.0 mg/kg < 1 min 3-5 min 5-10 min Intramuscular 2-4 mg/kg 2-5 min 20 min 30 min Poorly defined as 0.1-0.6 mg/kg IV 0.5-1.0 mg/kg IM (reference below) 0.5 mg/kg IN 70 kg male doses between 7 to 40 mg IV Nasal 5 mg/kg 10 min 20 min 1 hour 3

Why even consider? Clinical Scenario #1 May provide effective analgesia Can be given by a number of different routes Airway responses are protected Minimal cardiovascular effects Rapid onset, short duration of action, titratable A 13 year-old female with no sig PMH presents to the ED with a left arm deformity after a skateboard accident. Exam is significant for an obvious deformity above the right elbow. The patient is neurovascular intact distal to the injury site. She is crying and reports 9/10 pain. Gurnani A. et al. Analgesia for acute musculoskeletal trauma: low-dose subcutaneous infusion of ketamine. Anaesth Intensive Care 1996 Feb; 24(1): 32-6 Prospective cohort study in prehospital setting 27 patients Rx groups: Morphine vs. Morphine + ketamine Pain scores lower in morphine/ketamine group Blood pressure was high in morphine/ketamine group Conclusion: Morphine + LDK provides adequate pain relief in patients with bone fractures 40 adults with acute musculoskeletal trauma SQ ketamine 0.1 mg/kg/hr vs IV Morphine 0.1 mg/kg Pain relief better with ketamine (VAS) Patients in ketamine group had less drowsiness and were easier to mobilize (traction/splinting) Nausea and vomiting in morphine group high No pts in ketamine groups required supplemental analgesia 4

Gurnani A. et al. Analgesia for acute musculoskeletal trauma: low-dose subcutaneous infusion of ketamine. Anaesth Intensive Care 1996 Feb; 24(1): 32-6 Conclusion: Subcutaneous ketamine safe and effective analgesia in acute musculoskeletal trauma 65 trauma patient with acute pain IV morphine injection of 0.1 mg/kg, followed by 3 mg every 5 hours Placebo (saline) or ketamine 0.2 mg/kg over 10 minutes Ketamine group required much less morphine Ketamine group higher incidence of neuropsych side effects Intranasal ketamine for pain? Conclusion: Low dose ketamine reduced morphine requirements but with higher neuropsych side effects Case series of 40 patients with mod to severe pain IN ketamine 0.5 mg/kg initial bolus IN ketamine 0.25 mg/kg single repeat dose prn Objective pain measurements (VAS) 5

Intranasal ketamine for pain? Intranasal ketamine for pain? Conclusion: IN ketamine provides rapid, well-tolerated and clinically significant analgesia in ED patients Intranasal ketamine for pain? Intranasal ketamine? Prospective, randomized controlled equivalence trial Children with isolated musculoskeletal limb injury Rx groups: IN ketamine (1 mg/kg) vs IN fentanyl (1.5 ug/kg) Outcome = median change in pain scores Awaiting results... 6

Clinical Scenario #1 Clinical Scenario #1 A 13 year-old female with no sig PMH presents to the ED with a left arm deformity after a skateboard accident. Exam is significant for an obvious deformity above the right elbow. The patient is neurovascular intact distal to the injury site. She is crying and reports 9/10 pain. Several small studies suggest efficacy in this setting Intranasal route is compelling May obviate need for close respiratory monitoring More studies are needed Clinical Scenario #2 A 35 year old male with h/o IV heroin abuse presents with a left deltoid abscess. Exam sig for a 10 x 7 cm left lateral deltoid abscess. He complains of 10/10 pain and will barely allow you to touch his arm. He screams out in pain when the nurse attempts to place an IV. Home meds include methadone 120 mg daily. He is given a total of 4 mg of dilaudid without improvement in pain. How would you continue to manage of this patient? 2 year retrospective review of pts receiving ketamine in the ED LDK defined as < 0.6 mg/kg for pain control 35 cases identified Most common use was abscess Chronic pain medication use described in 80% of cases Low dose ketamine improved pain in 54% of cases 7

Evidence in opiate tolerant patients? Conclusion: ED physicians used low dose ketamine primarily in patient with high opiate tolerance Randomized, double blind study design Rx groups: Ketamine 0.1 mg/kg vs Placebo Both groups received intermittent doses of remifentanyl during the procedure Ketamine group required lower doses of opiates and had improved pain scores. Evidence in opiate tolerant patients? Conclusion: Preemptive bolus dose of ketamine has opiate sparing effects in opioid abusers undergoing moderate sedation 31 yo male with SCC Fentanyl PCA Oxycodone Ketorolac Methadone Venlafexine Gabapentin Doctor it s a 12!! After 30 days of admission, placed on ketamine infusion with marked improvement in pain. 8

Evidence in opiate tolerant patients? Clinical Scenario #2 14/17 cases showed improvement in pain A 35 year old male with h/o IV heroin abuse presents with a left deltoid abscess. Exam sig for a 10 x 7 cm left lateral deltoid abscess. He complains of 10/10 pain and will barely allow you to touch his arm. He screams out in pain when the nurse attempts to place an IV. Home meds include methadone 120 mg daily. He is given a total of 4 mg of dilaudid without improvement in pain. How would you continue to manage of this patient? Clinical Scenario #2 Clinical Scenario #3 Several small studies suggest a particular benefit of LDK in this patient population Likely reduces opiate consumption Needs to be studies in a controlled fashion in the emergency department setting. A 35 year-old male with a history of alcohol abuse presents brought in by medics after he was found down on the sidewalk with a large hematoma to his parietal scalp. Upon arrival in the emergency department he is agitated, spitting and attempting to hit multiple staff members. 9

Ketamine for agitation? Ketamine for agitation? Here using dissociative dosing 5 mg/kg IM Ketamine and agitation Ketamine and agitation Case series of psychiatric patients undergoing aeromedical transport. Initial ketamine dosing range given was 0.5-1 mg/kg. If two doses required infusion started at initial rate of 1-1.5 mg/kg per hour. Amount given titrated to achieve a calm, cooperative patient who could still respond to verbal commands. 4/19 patients with tachycardia and hypertension 1/19 vomiting but no intervention required No cases in which psychiatric symptoms were deemed to have worsened. Authors conclude: ketamine sedation valid and safe strategy for managing the agitation of psychiatric patients.aeromedical transport 10

What about ketamine and potential head injury? Clinical Scenario #3 Evidence that ketamine elevates ICP is weak No evidence that ketamine causes harm in TBI Ketamine s hemodynamic stability may be of benefit in TBI A 35 year-old male with a history of alcohol abuse presents brought in by medics after he was found down on the sidewalk with a large hematoma to his parietal scalp. Upon arrival in the emergency department he is agitated, spitting and attempting to hit multiple staff members. Clinical Scenario #3 Intriguing data from case reports and case series Higher doses may be required Concern of administration in psychiatric patients may be overblown Need more ED based studies Clinical Scenario #4 A 16 year-old female with h/o severe asthma and prior intubations presents with acute onset of SOB and wheezing. Exam is significant for hypoxia with O2 sat 90%, tachypnea, and wheezes with diminished air movement bilaterally. She is initially treated with albuterol, atrovent, and steroids without significant improvement. 11

Low dose ketamine in the asthmatic Low dose ketamine in the asthmatic Randomized, double blind, placebo controlled study design 68 patients enrolled Rx groups: ketamine (0.2 mg/kg + infusion) vs placebo Outcome: validated asthma score Results: No difference between the two groups Conclusion: Low dose ketamine had no incremental benefit compared with placebo Clinical Scenario #4 Clinical Scenario #4 A 16 year-old female with h/o severe asthma and prior intubations presents with acute onset of SOB and wheezing. Exam is significant for hypoxia with O2 sat 90%, tachypnea, and wheezes with diminished air movement bilaterally. She is initially treated with albuterol, atrovent, and steroids without significant improvement. No real indication for low dose ketamine here Higher doses of ketamine may be beneficial Furthers studies needed 12

The bottom line... Thank You Multiple studies demonstrate LDK effective in the treatment of acute pain. LDK appears reduces opiate requirements LDK may be particularly effective in patient with high opioid tolerance Unclear utility of low dose ketamine in the agitated patient LDK does not appear to improve outcomes in nonintubated asthmatics Questions? References Johansson P, et. al The effect of combined treatment with morphine sulphate and low-dose ketamine in a prehospital setting, Scandinavian Journal of Trauma, Resuscitation and Emergency Medicine Gurnani A. et al. Analgesia for acute musculoskeletal trauma: low-dose subcutaneous infusion of ketamine. Anaesth Intensive Care 1996 Feb; 24(1): 32-6 Galinski M, et al. Management of severe acute pain in emergency settings: ketamine reduces morphine consumption. Am J Emerg Med. 2007;25:385-390. Andolfatto, G et. al, Intranasal Ketamine for Analgesia in the Emergency Department: A Prospective Observation Series. Academic Emergency Medicine. Oct 2013;20(10) 1050-4 Lester L, Braude DA, Niles C, Crandall CS, et al. Low-dose ketamine for analgesia in the ED: a retrospective case series. Am J Emerg Med. 2010;28:820-876 Gharaei B, et. al. Opioid-Sparing Effect of Preemptive Bolus Low-Dose Ketamine for Moderate Sedation in Opioid Abusers Undergoing Extracorporeal Shock Wave Lithotripsy: A Randomized Clinical Trial. Anesthesia and Analgesia Jan 2013; 116(1) 75-80 Uprety D, et. al Ketamine infusion for sickle cell pain crisis refractory to opioids: a case report and review of literature Roberts J., et al. Intramuscular ketamine for the Rapid Tranquilization of the Uncontrollable, Violent, and Dangerous Adult Patient. J Trauma. 2001;51:1008-1010 Cong M, et. al. Ketamine sedation for patients with acute agitation and psychiatric illness requiring aeromedical retrieval Emerg Med J 2012 29:335-337 Allen J, et. al. The Efficacy of Ketamine in Pediatric Emergency Department Patients Who Present With Acute Severe Asthma. J of Emer Med 2011, 41(5)492-494 13